Investors

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Apr 1, 2013 goldstein joseph l Director Automatic Sell 5,000 180.00
Feb 14, 2012 goldstein joseph l Director Automatic Sell 15,000 110.02
Jan 19, 2012 goldstein joseph l Director Automatic Sell 10,000 80.00
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Mar 26, 2012 goldstein joseph l Director Automatic Sell 5,000 120.00
Jan 10, 2012 goldstein joseph l Director Automatic Sell 20,000 74.35 - 75.00
Oct 14, 2011 goldstein joseph l Director Automatic Sell 10,000 65.00
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Jan 4, 2013 goldstein joseph l Director Automatic Sell 5,000 180.50 - 181.22
Nov 5, 2007 goldstein joseph l Director Automatic Sell 4,200 20.38 - 20.63
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Jan 22, 2008 goldstein joseph l Director Automatic Sell 5,000 25.00
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
Dec 16, 2010 goldstein joseph l Director Automatic Sell 4,719 31.80
Dec 17, 2010 goldstein joseph l Director Automatic Sell 5,281 32.00
Oct 5, 2010 goldstein joseph l Director Automatic Sell 3,152 28.40
Nov 23, 2010 goldstein joseph l Director Automatic Sell 5,669 29.81
Nov 24, 2010 goldstein joseph l Director Automatic Sell 4,331 30.06
Mar 9, 2011 goldstein joseph l Director Automatic Sell 3,495 39.35
Jan 26, 2011 goldstein joseph l Director Automatic Sell 4,599 34.35
Showing 161-180 of 841 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)